S.A. Mason LLC Purchases 204 Shares of Colgate-Palmolive (NYSE:CL)

S.A. Mason LLC raised its position in Colgate-Palmolive (NYSE:CL) by 6.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,435 shares of the company’s stock after acquiring an additional 204 shares during the period. S.A. Mason LLC’s holdings in Colgate-Palmolive were worth $312,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of CL. Peak Financial Advisors LLC acquired a new position in Colgate-Palmolive during the 4th quarter valued at about $1,315,000. Gordian Advisors LLC acquired a new stake in Colgate-Palmolive in the 3rd quarter worth approximately $602,000. Carrera Capital Advisors grew its position in Colgate-Palmolive by 23.1% during the 3rd quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after purchasing an additional 7,353 shares during the last quarter. Fiduciary Alliance LLC acquired a new position in Colgate-Palmolive during the 4th quarter valued at approximately $4,066,000. Finally, Vontobel Holding Ltd. raised its holdings in shares of Colgate-Palmolive by 224.6% in the third quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company’s stock worth $82,626,000 after buying an additional 550,750 shares during the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $86.64 on Monday. The company has a fifty day simple moving average of $91.35 and a 200-day simple moving average of $97.17. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46. The firm has a market capitalization of $70.78 billion, a price-to-earnings ratio of 24.61, a PEG ratio of 3.61 and a beta of 0.44. Colgate-Palmolive has a 52-week low of $82.68 and a 52-week high of $109.30.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the prior year, the business posted $0.87 earnings per share. On average, equities analysts anticipate that Colgate-Palmolive will post 3.74 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.31%. Colgate-Palmolive’s dividend payout ratio is presently 56.82%.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. Barclays cut their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. Wells Fargo & Company dropped their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. TD Cowen decreased their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Royal Bank of Canada restated a “sector perform” rating and set a $101.00 target price on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Finally, UBS Group cut their price target on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a research report on Thursday, January 16th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $102.00.

Insider Activity

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This represents a 55.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 0.37% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.